Compared to Q2 2023, we have decreased our operating expenses by more than $600 million in Q2 2024. This reduction highlights our commitment to operational efficiency and financial discipline.

Moderna (MRNA) reports Q2 earnings before market open on Aug. 3. Can it keep earnings and revenue soaring as the global COVID-19 pandemic eases?

Moderna will announce Q2 2024 earnings on Aug. 1. See why I'm a little bearish on MRNA stock ahead of its Q2 earnings and there could be a post-earnings dip.

Moderna (MRNA) beats expectations for earnings and sales. Management cuts sales guidance by $0.5-$1.0 billion on concerns about competition for its marketed products and low sales in the EU.

/ April 10, 2025 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 1, 2025 to report its first quarter 2025 ...

Moderna recorded a $499 million write-off in Q2 due to vaccine doses that expired or were about to expire.

Investors will likely focus on updates on Moderna's (MRNA) pipeline, especially its late-stage pipeline candidates when it reports second-quarter earnings.

Moderna’s financial results for the second quarter of 2024 reveal a mixed bag of outcomes. The company reported total revenue of $241 million, down from $344 million in the same period last year ...

Moderna Inc (NasdaqGS: MRNA) shares surged Wednesday, lifting biotechnology sector-related exchange traded funds, after the pharmaceutical company revealed better-than-expected profit and revenue ...

Moderna anticipates that for sales in the second half, sales will be greater in the fourth quarter than the third quarter, driven by the timing for approval of its updated COVID-19 vaccines.

Moderna Inc. (NASDAQ:MRNA) Q2 2024 Earnings Conference Call August 1, 2024 8:00 AM ETCompany ParticipantsStéphane Bancel - Chief Executive OfficerStephen ...